Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2012
09/26/2012EP2501693A1 Novel heterocyclic acrylamides and their use as pharmaceuticals
09/26/2012EP2501692A1 Method for producing dabigatran etexilate
09/26/2012EP2501691A1 Substituted pyrrolidine-2-carboxamides
09/26/2012EP2501681A1 Zwitterion-containing acridinium compounds
09/26/2012EP2501678A1 Aryl-pyridine derivatives as aldosterone synthase inhibitors
09/26/2012EP2501387A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
09/26/2012EP2501233A1 Quinazoline compounds
09/26/2012CN1938294B Novel pyrrolidine-3,4-dicarboxamide derivatives
09/26/2012CN1914225B HCV NS-3 serine protease inhibitors
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN102695704A Indole derivatives and methods for antiviral treatment
09/26/2012CN102695699A Aminopropenoates as fungicides
09/26/2012CN102690259A Compound with function of diuresis, preparation method and functions thereof
09/26/2012CN102690258A Nitrogenous heterocyclic-imide derivative and preparation method and purpose thereof
09/26/2012CN102690257A Anthranilamide compound and application thereof
09/26/2012CN102690240A Tolyltriazole alkene ether compounds and oxime ether compounds and preparation method and application thereof
09/26/2012CN102336739B Loratadine compound and preparation method thereof
09/26/2012CN102082230B Infrared organic electroluminescent device
09/26/2012CN101808992B 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
09/26/2012CN101671326B Microbial treatment technology for extracting nicotine
09/26/2012CN101611015B Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
09/26/2012CN101607957B Intermediate for preparing 3-halo-4,5-dihydro-1h-pyrazoles
09/26/2012CN101583365B Triazine derivatives and their therapeutical applications
09/26/2012CN101497604B Benzimidazole derivative containing alkoxy acetamide substituted pyridine
09/26/2012CN101056869B Method and apparatus for producing oxidized compound
09/25/2012USRE43688 Compositions and methods related to serotonin 5-HT1A receptors
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273770 5-pyridinone substituted indazoles
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273764 Fused heterocyclic compounds and use thereof
09/25/2012US8273749 N-substituted oxindoline derivatives as calcium channel blockers
09/25/2012US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/25/2012US8273341 Antiviral compounds
09/25/2012CA2683124C Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
09/25/2012CA2679530C Benzimidazole compound and pharmaceutical use thereof
09/25/2012CA2560071C Lysine based compounds
09/25/2012CA2547654C Use of osteopontin in dental formulations
09/25/2012CA2516822C Method for preparing acid addition salts of polyacidic basic compound
09/25/2012CA2443159C Liquid formulations for dermal application in treatment of parasitic insects in animals
09/20/2012WO2012125981A2 Raf kinase inhibitors
09/20/2012WO2012125913A1 Methods and use of bifunctional enzyme-building clamp-shaped molecules
09/20/2012WO2012125832A2 Antimicrobial agents
09/20/2012WO2012125447A2 Piperazinedione compounds
09/20/2012WO2012125438A1 Solid forms of 3-(5-amino-2methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/20/2012WO2012125091A1 Process for producing melanin using cultures of the genus nigella
09/20/2012WO2012124825A1 Sulfonamide compounds having trpm8 antagonistic activity
09/20/2012WO2012124744A1 Nitrogen-containing condensed heterocyclic compound
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124311A1 Novel phenylpyridine derivative and drug containing same
09/20/2012WO2012123563A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase
09/20/2012WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012WO2012123468A1 New azaspirodecanone compounds
09/20/2012WO2012123467A1 Pyrimidine amide compounds
09/20/2012WO2012123449A1 N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators
09/20/2012WO2012123434A1 Fungicide hydroximoyl-tetrazole derivatives
09/20/2012WO2012123311A1 Pyridinyl- and pyrazinyl -methyloxy - aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
09/20/2012WO2012122891A1 Oxime-containing amino derivative, pharmaceutical composition, preparation method and use thereof
09/20/2012WO2012122865A2 Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
09/20/2012WO2012122605A1 Iridium based complex for water splitting
09/20/2012WO2012089828A3 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/20/2012US20120238752 Compound or its tautomer, metal complex compound, colored photosensitive curing composition, color filter, and production
09/20/2012US20120238750 Aromatic compound
09/20/2012US20120238602 Piperidine sulphonamide derivatives
09/20/2012US20120238594 Azaspirodecanone compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238581 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
09/20/2012US20120238578 Compositions useful as inhibitors of voltage-gated sodium channels
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238575 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones
09/20/2012US20120238574 (1, 1, 1,3,3,3 -hexafluoro-2 hydroxypropan- 2 -yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis
09/20/2012US20120238573 Prodrugs of [4 [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1h-pyrrolo-pyridin-yl)-methanones and synthesis thereof
09/20/2012US20120238566 Use of cell autophagy (type ii cell apoptosis) inhibitors
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238550 Compound
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120237874 Actinic-Ray- or Radiation-Sensitive Resin Composition, Compound and Method of Forming Pattern Using the Composition
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120235129 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830115A1 New azaspirodecanone compounds
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829993A1 Antimicrobial agents
09/20/2012CA2829614A1 Process for producing melanin using cultures of the genus nigella
09/20/2012CA2829570A1 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/20/2012CA2829088A1 Piperazinedione compounds
09/20/2012CA2828518A1 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk)
09/20/2012CA2827161A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012CA2826678A1 Sulfonamide compounds having trpm8 antagonistic activity
09/19/2012EP2499127A1 Hepatitis c virus inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2499125A1 Process for the resolution of omeprazole
09/19/2012EP2499124A1 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
09/19/2012EP2499121A1 Oxazoline derivatives for treatment of cns disorders.
09/19/2012EP2499117A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
09/19/2012EP2498756A1 Tablet formulations of neratinib maleate
09/19/2012CN102686580A Imidazole derivative as casein kinase inhibitors
09/19/2012CN102686579A Compounds and compositions as modulators of GPR119 activity
09/19/2012CN102686578A Bicyclic heteroaryl inhibitors of PDE4
09/19/2012CN102686577A Compounds as tyrosine kinase modulators
1 ... 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 ... 1080